packageBimekizumab

bimekizumab

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Bimekizumab is a monoclonal antibody used to treat psoriasis. It is an approved interleukin inhibitor authorised in the European Union.

Summary written by glm-5.3-flash from Wikidata Q60785566 and the WHO ATC classification and the EMA medicines list; not checked by a person.

name:bimekizumab
ATC codes:L04AC21
DrugBank:DB12917
Wikidata:Q60785566

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown